-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Outperform on HCA Healthcare, Lowers Price Target to $376

Benzinga·04/28/2025 16:11:51
Listen to the news
RBC Capital analyst Ben Hendrix maintains HCA Healthcare (NYSE:HCA) with a Outperform and lowers the price target from $384 to $376.